Clinical trial • Phase I • Oncology
JNJ-87890387 for Advanced solid tumors
Phase I trial of JNJ-87890387 for Advanced solid tumors. None/Not specified-controlled. 70 participants.
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- Advanced solid tumors
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 05-12-2023
- First CTIS Authorization Date
- 20-03-2024
Trial design
None/Not specified-controlled Phase I trial in France, Spain.
- Comparator
- None/Not specified
- Target Sample Size
- 70
Recruitment
- Planned Sample Size
- 70
- Recruitment Window Months
- 51
Geography
- Total Number Of Sites
- 4
- Total Number Of Participants
- 130
France
- Earliest CTIS Part Ii Submission Date
- 25-03-2024
- Latest Decision Or Authorization Date
- 23-03-2026
- Processing Time Days
- 728
- Number Of Sites
- 2
- Number Of Participants
- 68
Sites
- Site Name
- Institut Gustave Roussy
- Department Name
- Oncology Drud Development Department (DITEP)
- Principal Investigator Name
- Kaissa OUALI
- Principal Investigator Email
- kaissa.ouali@gustaveroussy.fr
- Contact Person Name
- Kaissa OUALI
- Contact Person Email
- kaissa.ouali@gustaveroussy.fr
- Site Name
- Centre Leon Berard
- Department Name
- Medical oncology
- Principal Investigator Name
- Armelle VINCENEUX
- Principal Investigator Email
- armelle.vinceneux@lyon.unicancer.fr
- Contact Person Name
- Armelle VINCENEUX
- Contact Person Email
- armelle.vinceneux@lyon.unicancer.fr
Spain
- Earliest CTIS Part Ii Submission Date
- 01-03-2024
- Latest Decision Or Authorization Date
- 27-03-2026
- Processing Time Days
- 756
- Number Of Sites
- 2
- Number Of Participants
- 62
Sites
- Site Name
- Hospital Universitario 12 De Octubre
- Department Name
- Medical Oncology
- Principal Investigator Name
- Guillermo De Velasco
- Principal Investigator Email
- guillermoantonio.velasco@salud.madrid.org
- Contact Person Name
- Guillermo De Velasco
- Contact Person Email
- guillermoantonio.velasco@salud.madrid.org
- Site Name
- Hospital Universitari Vall D Hebron
- Department Name
- Medical Oncology
- Principal Investigator Name
- Elena Garralda
- Principal Investigator Email
- egarralda@vhio.net
- Contact Person Name
- Elena Garralda
- Contact Person Email
- egarralda@vhio.net
Sponsor
Primary sponsor
- Full Name
- Janssen - Cilag International
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Belgium
Investigational products
- Investigational Product Name
- JNJ-87890387
Related trials
Other published trials that may interest you.